| SC 13D/A | 2021-09-14 | TAKEDA PHARMACEUTICAL CO LTD | Molecular Templates, Inc. | - | 4.1% | EDGAR |
| SC 13G/A | 2021-04-26 | BB BIOTECH AG | Molecular Templates, Inc. | 9,542,621 | 17.0% | EDGAR |
| SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Molecular Templates, Inc. | 601,818 | 1.2% | EDGAR |
| SC 13G/A | 2021-02-12 | BB BIOTECH AG | Molecular Templates, Inc. | 6,380,331 | 12.8% | EDGAR |
| SC 13G/A | 2021-02-11 | BIOTECHNOLOGY VALUE FUND L P | Molecular Templates, Inc. | 1,432,016 | 2.9% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Molecular Templates, Inc. | 3,078,709 | 6.2% | EDGAR |
| SC 13G/A | 2020-11-04 | BB BIOTECH AG | Molecular Templates, Inc. | 5,229,996 | 10.5% | EDGAR |
| SC 13D/A | 2020-09-18 | SANTE HEALTH VENTURES I LP | Molecular Templates, Inc. | 6,116,608 | 13.4% | EDGAR |
| SC 13D/A | 2020-06-05 | Longitude Capital Partners III, LLC | Molecular Templates, Inc. | 4,647,302 | 9.9% | EDGAR |
| SC 13D/A | 2020-05-04 | SANTE HEALTH VENTURES I LP | Molecular Templates, Inc. | 6,916,608 | 15.1% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Molecular Templates, Inc. | 1,827,309 | 4.2% | EDGAR |
| SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | Molecular Templates, Inc. | 3,164,133 | 7.3% | EDGAR |
| SC 13G | 2020-01-29 | BB BIOTECH AG | Molecular Templates, Inc. | 2,161,152 | 5.0% | EDGAR |
| SC 13D/A | 2019-12-05 | Longitude Capital Partners III, LLC | Molecular Templates, Inc. | 5,647,302 | 12.5% | EDGAR |
| SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | Molecular Templates, Inc. | 1,576,712 | 4.3% | EDGAR |
| SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | Molecular Templates, Inc. | 2,164,133 | 5.9% | EDGAR |
| SC 13G/A | 2019-02-06 | Excel Venture Fund II, L.P. | Molecular Templates, Inc. | 1,497,696 | 4.1% | EDGAR |
| SC 13G | 2018-10-01 | BIOTECHNOLOGY VALUE FUND L P | Molecular Templates, Inc. | 1,329,237 | 3.8% | EDGAR |
| SC 13G | 2018-09-27 | PERCEPTIVE ADVISORS LLC | Molecular Templates, Inc. | 1,975,133 | 5.6% | EDGAR |
| SC 13D/A | 2018-09-26 | Longitude Capital Partners III, LLC | Molecular Templates, Inc. | 4,709,802 | 12.4% | EDGAR |